These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17466303)

  • 1. Reducing maternal mortality due to elective abortion: Potential impact of misoprostol in low-resource settings.
    Harper CC; Blanchard K; Grossman D; Henderson JT; Darney PD
    Int J Gynaecol Obstet; 2007 Jul; 98(1):66-9. PubMed ID: 17466303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misoprostol and women's health in Africa.
    Okonofua F
    Afr J Reprod Health; 2005 Apr; 9(1):7-9, 10-3. PubMed ID: 16104649
    [No Abstract]   [Full Text] [Related]  

  • 3. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion.
    Briozzo L; Vidiella G; Rodríguez F; Gorgoroso M; Faúndes A; Pons JE
    Int J Gynaecol Obstet; 2006 Nov; 95(2):221-6. PubMed ID: 17010348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safe abortion information hotlines: An effective strategy for increasing women's access to safe abortions in Latin America.
    Drovetta RI
    Reprod Health Matters; 2015 May; 23(45):47-57. PubMed ID: 26278832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Legalized abortions reduced maternal mortality in South Africa. Morbidity and mortality before and after the change of legislation].
    Bendz E; Liljequist VA; Bergström S
    Lakartidningen; 2008 Oct 8-14; 105(41):2855-7. PubMed ID: 19009900
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of misoprostol in termination of second-trimester pregnancy.
    Lin CJ; Chien SC; Chen CP
    Taiwan J Obstet Gynecol; 2011 Sep; 50(3):275-82. PubMed ID: 22030039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misoprostol priming prior to second trimester medical abortion.
    Moreno-Ruiz NL; Vesona JL; Betstadt SJ; Feng KT; Borgatta L
    Int J Gynaecol Obstet; 2009 Jul; 106(1):67-8. PubMed ID: 19358989
    [No Abstract]   [Full Text] [Related]  

  • 8. Acceptability and feasibility of medical abortion in Nepal.
    Karki C; Pokharel H; Kushwaha A; Manandhar D; Bracken H; Winikoff B
    Int J Gynaecol Obstet; 2009 Jul; 106(1):39-42. PubMed ID: 19345944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm Reduction for Abortion in the United States.
    Tasset J; Harris LH
    Obstet Gynecol; 2018 Apr; 131(4):621-624. PubMed ID: 29528924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Termination of pregnancy with misoprostol in the scarred uterus.
    van Bogaert LJ
    Int J Gynaecol Obstet; 2008 Jan; 100(1):80-1. PubMed ID: 17888919
    [No Abstract]   [Full Text] [Related]  

  • 11. How to manage unresponsiveness to misoprostol in failed second trimester pregnancy termination.
    Pongsatha S; Tongsong T
    J Obstet Gynaecol Res; 2013 Jan; 39(1):154-9. PubMed ID: 22691227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Randomized study of sulprostone versus misoprostol in the cervical preparation before elective abortion in nulliparous women].
    Schaub B; Fuhrer P; Sainte-Rose D
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(5):505-10. PubMed ID: 7499737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misoprostol and the debate over off-label drug use.
    Weeks AD; Fiala C; Safar P
    BJOG; 2005 Mar; 112(3):269-72. PubMed ID: 15713138
    [No Abstract]   [Full Text] [Related]  

  • 14. Midtrimester abortion using vaginal misoprostol for women with three or more prior cesarean deliveries.
    Fawzy M; Abdel-Hady el-S
    Int J Gynaecol Obstet; 2010 Jul; 110(1):50-2. PubMed ID: 20362989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone-misoprostol midtrimester abortion: impact of gestational age on the induction-to-abortion interval.
    Gómez O; Borrás A; Rabanal A; Palacio M; Carceller A; Coll O; Gratacós E
    Contraception; 2010 Feb; 81(2):97-101. PubMed ID: 20103444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of mifepristone and misoprostol for the termination of pregnancy.
    ;
    Int J Gynaecol Obstet; 2011 Oct; 115(1):1-4. PubMed ID: 21872858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of misoprostol in the termination of missed abortion].
    Szymańska M; Suchońska B; Ziółkowska K; Bablok L
    Med Wieku Rozwoj; 2003; 7(3 Suppl 1):307-12. PubMed ID: 15537276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean.
    Duley L
    Br J Obstet Gynaecol; 1992 Jul; 99(7):547-53. PubMed ID: 1525093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.